Primary efficacy and updated safety of ceritinib (450 mg or 600 mg) with food vs 750 mg fasted in ALK+ metastatic NSCLC (ASCEND-8)
Byoung Chul Cho(Yonsei University), Radka Obermannová(Masaryk University), Sergey Orlov(First Pavlov State Medical University of St. Petersburg), Ullas Batra(Rajiv Gandhi Cancer Institute and Research Centre), Sarayut Lucien Geater(Prince of Songkla University), Mark J. McKeage(University of Auckland), Cheng‐Ta Yang(Chang Gung Memorial Hospital), Pieter E. Postmus(Leiden University Medical Center), Gilberto de Castro(Instituto do Câncer do Estado de São Paulo), Seung‐Whan Kim(Ulsan College), Pedro De Marchi(Hospital de Câncer de Barretos), Govind Babu Kanakasetty(Kidwai Memorial Institute of Oncology), Virote Sriuranpong(Chulalongkorn University), P.J. Voon(Sarawak General Hospital), Yvonne Lau(Novartis (United States)), Flavia Kiertsman, Vanessa Q. Passos(Novartis (United States)), Z. Chen, Rafał Dziadziuszko(Gdańsk Medical University)
Cited by 2
Abstract
Related Papers
No related papers found
Powered by citation graph analysis